| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.2000.TB06399.X |
| P698 | PubMed publication ID | 10818538 |
| P50 | author | Monique Breteler | Q19609784 |
| P2860 | cites work | Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study | Q28237067 |
| Dietary fat intake and the risk of incident dementia in the Rotterdam Study | Q34065622 | ||
| Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
| Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study | Q36885972 | ||
| Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease | Q36902693 | ||
| Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study | Q36903154 | ||
| Determinants of disease and disability in the elderly: The Rotterdam elderly study | Q42020555 | ||
| Cerebral white matter lesions and atherosclerosis in the Rotterdam Study | Q44225072 | ||
| Incidence and risk of dementia. The Rotterdam Study | Q45282189 | ||
| Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study | Q47887017 | ||
| Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study | Q48093220 | ||
| Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study | Q48108447 | ||
| Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. | Q50972617 | ||
| Association of diabetes mellitus and dementia: the Rotterdam Study. | Q50989914 | ||
| Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. | Q51982799 | ||
| beta-Amyloid-mediated vasoactivity and vascular endothelial damage. | Q53211170 | ||
| Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study. | Q53229640 | ||
| Diabetes mellitus and the risk of dementia: The Rotterdam Study. | Q53231897 | ||
| Resistance to activated protein C as a basis for venous thrombosis. | Q54214042 | ||
| NSAIDs and incident Alzheimer’s disease. the Rotterdam study | Q57782138 | ||
| Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 | ||
| Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study | Q57782164 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 457-465 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study | |
| P478 | volume | 903 |
| Q48245310 | A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. |
| Q45971996 | A brief update on dementia prevention. |
| Q30635401 | A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice |
| Q36106834 | Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease |
| Q24649729 | Ageing and the brain |
| Q33989502 | Aggregation of vascular risk factors and risk of incident Alzheimer disease |
| Q90203824 | Aging-associated changes in cerebral vasculature and blood flow as determined by quantitative optical coherence tomography angiography |
| Q35806684 | Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin. |
| Q35841706 | Alzheimer's disease is a vasocognopathy: a new term to describe its nature |
| Q38101981 | Antihypertensives, angiotensin, glucose and Alzheimer's disease. |
| Q36812780 | Arterial hypertension and cognitive dysfunction in physiologic and pathologic aging of the brain |
| Q48420488 | Association between blood pressure levels over time and brain atrophy in the elderly. |
| Q33767858 | Association between total-Tau and brain atrophy one year after first-ever stroke |
| Q93047126 | Association of Transfusion With Risks of Dementia or Alzheimer's Disease: A Population-Based Cohort Study |
| Q53360662 | Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease. |
| Q78431472 | Atrial fibrillation: an old disease, a new epidemic |
| Q30483111 | B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice |
| Q35992284 | Baseline cardiovascular risk predicts subsequent changes in resting brain function |
| Q31007958 | Brain health and shared risk factors for dementia and stroke |
| Q40507083 | Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease? |
| Q37238561 | Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial |
| Q35801866 | Cardiovascular risk factors and Alzheimer's disease |
| Q36455581 | Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia |
| Q48935577 | Cell cycle proteins preceded neuronal death after chronic cerebral hypoperfusion in rats |
| Q34224715 | Cerebral microvascular pathology in aging and Alzheimer's disease |
| Q36317585 | Cholesterol in Alzheimer's disease |
| Q30544139 | Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease |
| Q48187646 | Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease |
| Q33574306 | Cognition and incident coronary heart disease in late midlife: The Whitehall II study |
| Q36582766 | Congestive heart failure and Alzheimer's disease |
| Q35827883 | Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults |
| Q35037752 | Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. |
| Q30576714 | Current neuroimaging techniques in Alzheimer's disease and applications in animal models |
| Q48767137 | DNA damage response and senescence in endothelial cells of human cerebral cortex and relation to Alzheimer's neuropathology progression: a population-based study in the Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort |
| Q37970511 | Dementia, stroke, and vascular risk factors; a review |
| Q35189671 | Depression in Alzheimer's disease: heterogeneity and related issues |
| Q35594507 | Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine |
| Q33199272 | Enhanced cutaneous vascular response in AD subjects under donepezil therapy |
| Q36754702 | Exposure to particulate air pollution and cognitive decline in older women |
| Q44562476 | Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. |
| Q35196415 | Hemodynamic effects of combined focal cerebral ischemia and amyloid protein toxicity in a rat model: a functional CT study |
| Q33965772 | Heparin oligosaccharides as potential therapeutic agents in senile dementia |
| Q36254312 | Hippocampal complex atrophy in poststroke and mild cognitive impairment |
| Q37339994 | History of coronary heart disease and cognitive performance in midlife: the Whitehall II study |
| Q44246021 | Homocysteine and brain atrophy on MRI of non-demented elderly |
| Q23915645 | Homocysteine and cognitive function in a population-based study of older adults |
| Q37551271 | Hypertension, dementia, and antihypertensive treatment: implications for the very elderly. |
| Q35064010 | Impact of aerobic exercise on neurobehavioral outcomes |
| Q26825419 | Impact of age-related neuroglial cell responses on hippocampal deterioration |
| Q36233972 | Impact of metabolic syndrome on cognition and brain: a selected review of the literature |
| Q45259615 | Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes |
| Q33628048 | Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease |
| Q30908064 | Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics |
| Q41767433 | L-arginine and Alzheimer's disease. |
| Q24651195 | Long working hours and cognitive function: the Whitehall II Study |
| Q33492926 | Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? |
| Q33899973 | Neuropsychological contributions to the early identification of Alzheimer's disease |
| Q33941073 | Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study |
| Q39784495 | One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial. |
| Q44512981 | Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation |
| Q38034108 | Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease |
| Q36267683 | Serum phosphorus levels and risk of incident dementia |
| Q47978827 | Serum proteomics in amnestic mild cognitive impairment |
| Q30844186 | Structural imaging measures of brain aging |
| Q92378165 | Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models |
| Q36299324 | The Impact of Admission Diagnosis on Recurrent or Frequent Hospitalizations in 3 Dementia Subtypes: A Hospital-Based Cohort in Taiwan with 4 Years Longitudinal Follow-Ups |
| Q36877518 | The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline |
| Q36365616 | The thyroid hormone receptor alpha locus and white matter lesions: a role for the clock gene REV-ERBα. |
| Q57621243 | The thyroid hormone receptor α locus and white matter lesions: a role for the clock gene REV-ERBα |
| Q33917017 | The type A behavior pattern and cardiovascular disease as predictors of dementia |
| Q51894479 | The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women. |
| Q30826339 | Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise. |
| Q47408299 | Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. |
| Q53365863 | Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. |
| Q37299896 | Vascular factors and prevention of dementia. |
| Q40132143 | White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory |
| Q48556611 | White matter lesions and soluble interleukin-1 receptor type II in CSF from demented and non-demented subjects |
Search more.